miR-101-3p is decreased in BCBM leading to increased expression of COX-2 and stimulation of COX-2/MMP-1 signaling pathway, promoting trans-endothelial migration of breast cancer cells and extravasation across the BBB (78). Here, MMP1 is linked to breast cancer.